You have 9 free searches left this month | for more free features.

UGT1A1

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

UGT1A1 Genotyping in Taiwanese Cancer Patients

Not yet recruiting
  • The Influence of the UGT1A1 Genotype
    • (no location specified)
    Mar 20, 2023

    Metastatic Pancreatic Cancer Trial in Singapore (Low Dose OXIRI (LD-OXIRI))

    Not yet recruiting
    • Metastatic Pancreatic Cancer
    • Low Dose OXIRI (LD-OXIRI)
    • Singapore, Singapore
      National Cancer Centre, Singapore
    Jun 29, 2023

    Immune System Disorder (Healthy Volunteers) Trial in Miami (Belumosudil, UGT1A1 victim drug, P-gp victim drug)

    Completed
    • Immune System Disorder (Healthy Volunteers)
    • Miami, Florida
      Investigational Site Number: 8400001
    Apr 11, 2023

    Metastatic Colorectal Cancer Trial in Kaohsiung (UGT1A1 genotyping (6,6), UGTIA1 genotyping (6,7), UGTIA1 genotyping (7,7))

    Completed
    • Metastatic Colorectal Cancer
    • UGT1A1 genotyping (6,6)
    • +7 more
    • Kaohsiung, Taiwan
      Chung-Ho Memorial Hospital, Kaohsiung Medical University:
    Nov 9, 2021

    (CMS), UGT1A1 Genotype and Beta-glucuronidase Activity of

    Recruiting
    • Colorectal Neoplasms
      • Maastricht, Limburg, Netherlands
        Maastricht UMC+
      Jan 10, 2023

      Cancer Trial in Ann Arbor (DPYD or UGT1A1 variants)

      Not yet recruiting
      • Cancer
      • DPYD or UGT1A1 variants
      • Ann Arbor, Michigan
        University of Michigan Rogel Cancer Center
      Dec 20, 2022

      Rectal Cancer Stage III Trial in Hangzhou (Neoadjuvant chemoradiotherapy based on irinotecan)

      Recruiting
      • Rectal Cancer Stage III
      • Neoadjuvant chemoradiotherapy based on irinotecan
      • Hangzhou, Zhejiang, China
        Zhejiang Cancer Hospital
      Dec 7, 2021

      Gastrointestinal Cancer, Breast Cancer, Head Neck Cancer Trial in Chicago (Pharmacogenomics (PGx) Testing and Genomics

      Recruiting
      • Gastrointestinal Cancer
      • +4 more
      • Availability of clinical decision support based on pharmacogenomic results.
      • Chicago, Illinois
        University of Chicago Medical Center
      Oct 20, 2022

      Solid Tumors, Hematological Malignancies Trial in Santa Monica, Whittier, Canton (Belinostat IV)

      Completed
      • Solid Tumors
      • Hematological Malignancies
      • Belinostat IV
      • Santa Monica, California
      • +2 more
      Sep 10, 2021

      Pancreatic Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Adenocarcinoma Trial in Chicago (Oxaliplatin, Docetaxel,

      Recruiting
      • Pancreatic Adenocarcinoma
      • +2 more
      • Chicago, Illinois
        The University of Chicago
      Jun 7, 2021

      Crigler-Najjar Syndrome Trial in France, Italy, Netherlands (GNT0003)

      Recruiting
      • Crigler-Najjar Syndrome
      • GNT0003
      • Clamart, France
      • +3 more
      Jun 1, 2021

      Diabetes Trial in Gières (Sotagliflozin (SAR439954), Mefenamic acid)

      Completed
      • Diabetes Mellitus
      • Sotagliflozin (SAR439954)
      • Mefenamic acid
      • Gières, France
        Investigational site 250001
      Apr 21, 2022

      Colorectal Cancer Trial in France (bevacizumab, fluorouracil, irinotecan HCl)

      Completed
      • Colorectal Cancer
      • bevacizumab
      • +3 more
      • Abbeville, France
      • +31 more
      Nov 5, 2020

      Colorectal Cancer Trial (bevacizumab, filgrastim, fluorouracil)

      Completed
      • Colorectal Cancer
      • bevacizumab
      • +4 more
      • (no location specified)
      Mar 27, 2020

      Pharmacogenomics Trial (Indapamide 1.5 MG SR)

      Not yet recruiting
      • Pharmacogenomics
      • Indapamide 1.5 MG SR
      • (no location specified)
      Mar 15, 2022

      First Line Metastatic Colorectal Cancer Trial in Beaumont, Clermont-Ferrand (Irinotecan)

      Completed
      • First Line Metastatic Colorectal Cancer
      • Beaumont, France
      • +2 more
      Dec 24, 2019

      Esophageal Squamous Cell Carcinoma Abdominal Stage 0 Trial in Guangzhou (PD-1 Inhibitors, Irinotecan, Capecitabine tablets)

      Recruiting
      • Esophageal Squamous Cell Carcinoma Abdominal Stage 0
      • PD-1 Inhibitors
      • +2 more
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Feb 20, 2023

      Healthy Participants Trial in Lenexa (BMS-986165, diflunisal)

      Completed
      • Healthy Participants
      • Lenexa, Kansas
        PRA Health Sciences - Lenexa
      Aug 3, 2020

      CPT-11 Based Regimens and UGT1A1 Genotypes in Metastatic

      Completed
      • Metastatic Colorectal Cancer
      • CPT-11 based regimens
      • Tokorozawa-shi, Saitama, Japan
        Department of Clinical Oncology, National Defense Medical Colleg
      May 24, 2019

      Metastatic Colorectal Cancer Trial in Kaohsiung (Regorafenib, UGT1A1 genotyping (TA6/TA6), UGT1A1 genotyping (TA6/TA7))

      Unknown status
      • Metastatic Colorectal Cancer
      • Kaohsiung, Taiwan
        Chung-Ho Memorial Hospital, Kaohsiung Medical University:
      Mar 19, 2019

      CPT-11 Plus Platinum Analogues Regimens and UGT1A1 Genotypes in

      Completed
      • Small Cell Lung Cancer
      • +4 more
      • Tokorozawa, Japan
        Department of Obstetrics and Gynecology, National Defense Medica
      May 21, 2019

      Myotonic Dystrophy 1 Trial (ARO-DM1 for Injection, Placebo)

      Not yet recruiting
      • Myotonic Dystrophy 1
      • ARO-DM1 for Injection
      • Placebo
      • (no location specified)
      Nov 14, 2023

      Type 1 Diabetes, Type 1 Diabetes With Hypoglycemia, Type 1 Diabetes With Hyperglycemia Trial in Berne (Lab Demo 1.0)

      Not yet recruiting
      • Type 1 Diabetes Mellitus
      • +2 more
      • Lab Demo 1.0
      • Berne, Switzerland
        Markus Laimer
      Oct 23, 2023

      ALDH1A1 Expression in Invasive Mammary Carcinoma

      Enrolling by invitation
      • Breast Cancer
        • Sohag, Egypt
          Faculty of Medicine
        Nov 12, 2023

        MicroRNA-1 and MicroRNA-133a Levels After Acute Exercise in

        Recruiting
        • To Determine the Levels of miRNA1 and miRNA133a Before and After Exercise
        • miRNA levels analysis from saliva samples
        • Istanbul, Turkey
          Yeditepe University
        Oct 11, 2023